J&J attracts Chinese interest for its diabetes business in a potential $3B to $4B deal

Chinese bidders are circling Johnson & Johnson's diabetes care business in a deal that could fetch up to $4 billion.

from Mergers and Acquisitions http://ift.tt/2DoAVup